Cocrystal Pharma, Inc. Contracts & Agreements
109 Contracts & Agreements
- Business Finance (65 contracts)
- Business Operations (8)
- Human Resources (10)
- Intellectual Property (6)
- Mergers & Acquisitions (6)
- Uncategorized (14)
- Securities Purchase Agreement dated April 4, 2023 (Filed With SEC on April 10, 2023)
- Consulting and Scientific Advisory Board Agreement, dated April 13, 2021 with Roger Kornberg (Filed With SEC on August 16, 2021)
- Underwriting Agreement, dated as of May 4, 2021 by and between Cocrystal Pharma, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on May 5, 2021)
- Amended and Restated Underwriting Agreement, dated as of August 26, 2020, by and between Cocrystal Pharma, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on August 27, 2020)
- License Agreement dated April 19, 2020, between the Company and Kansas State University Research Foundation (Filed With SEC on August 6, 2020)
- At-The-Market Offering Agreement, dated July 1, 2020, by and between Cocrystal Pharma, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 2, 2020)
- License Agreement, dated February 18, 2020, between the Company and Kansas State University Research Foundation (Filed With SEC on May 13, 2020)
- Description of Capital Stock (Filed With SEC on March 27, 2020)
- Form of Securities Purchase Agreement, dated March 9, 2020, by and between the Company and the Purchasers (Filed With SEC on March 13, 2020)
- Form of Securities Purchase Agreement, dated February 27, 2020, by and between the Company and the Purchasers (Filed With SEC on March 4, 2020)
- Engagement letter dated February 26, 2020 by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on March 4, 2020)
- Placement Agency Agreement, dated as of January 29, 2020, by and between Cocrystal Pharma, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on January 31, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on January 31, 2020)
- Amendment to the Amended and Restated Equity Distribution Agreement, dated October 2, 2019 (Filed With SEC on January 29, 2020)
- Underwriting Agreement, dated as of October 30, 2019, by and between Cocrystal Pharma, Inc. and Aegis Capital Corp (Filed With SEC on October 31, 2019)
- Amended and Restated Equity Distribution Agreement, dated October 30, 2019 (Filed With SEC on October 30, 2019)
- Exclusive License and Research Collaboration Agreement between the Company and Merck Sharp & Dohme Corp., dated January 2, 2019 (Filed With SEC on April 1, 2019)
- Amendment to Equity Distribution Agreement, dated March 20, 2019 (Filed With SEC on March 26, 2019)
- Securities Purchase Agreement, dated March 11, 2019 (Filed With SEC on March 11, 2019)
- Equity Distribution Agreement, dated July 19, 2018 (Filed With SEC on July 20, 2018)
- Underwriting Agreement, dated as of April 30, 2018, by and between Cocrystal Pharma, Inc. and A.G.P./Alliance Global Partners as representative of the several underwriters (Filed With SEC on May 2, 2018)
- Form of Warrant (Filed With SEC on May 2, 2018)
- Form of Securities Purchase Agreement dated November 24, 2017 (Filed With SEC on December 1, 2017)
- Form of Convertible Note dated November 24, 2017 (Filed With SEC on December 1, 2017)
- CocrystalPharma, Inc. 1860Montreal Road Tucker,GA 30084 ###-###-#### May26, 2017 (Filed With SEC on June 1, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on April 24, 2017)
- CONTRACT CHIEF FINANCIAL OFFICER AGREEMENT (Filed With SEC on February 24, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 2, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 15, 2016)
- COCRYSTAL PHARMA, INC. (Filed With SEC on November 20, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on September 24, 2015)
- Cocrystal Pharma, Inc. (Filed With SEC on September 24, 2015)
- Cocrystal Pharma, Inc. (Filed With SEC on July 27, 2015)
- COCRYSTAL PHARMA, INC. 2015 EQUITY INCENTIVE PLAN, AS AMENDED NON-QUALIFIED STOCK OPTION AGREEMENT FOR WALT LINSCOTT Agreement (Filed With SEC on July 27, 2015)
- TERMINATION OF EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2015)
- FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2015)
- FORM OF SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 26, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 17, 2015)
- AGREEMENT AND PLAN OF MERGER BY AND AMONG COCRYSTAL PHARMA, INC., COCRYSTAL HOLDINGS, INC., COCRYSTAL MERGER SUB, INC., RFS MERGER SUB, LLC. AND RFS PHARMA, LLC. Dated as of... (Filed With SEC on December 1, 2014)
- CERTIFICATE OF MERGER (Filed With SEC on December 1, 2014)
- ARTICLES OF MERGER (Filed With SEC on December 1, 2014)
- FORM OF STOCKHOLDER RIGHTS AGREEMENT (Filed With SEC on December 1, 2014)
- COCRYSTAL DISCOVERY, INC. SHARE PURCHASE AGREEMENT (Filed With SEC on May 15, 2014)
- RESEARCH AND COLLABORATION AGREEMENT between TEVA PHARMACEUTICAL INDUSTRIES LIMITED and COCRYSTAL DISCOVERY, INC. Dated as of September 13, 2011 (Filed With SEC on May 15, 2014)
- EXCLUSIVE LICENSE OPTION AGREEMENT between TEVA PHARMACEUTICAL INDUSTRIES LIMITED and COCRYSTAL DISCOVERY, INC. Dated as of September 13, 2011 (Filed With SEC on May 15, 2014)
- CERTIFICATE OF MERGER OF BIOZONE PHARMACEUTICALS, INC. (a Nevada corporation) WITH AND INTO COCRYSTAL PHARMA, INC. (a Delaware corporation) Pursuant to Section 252 of the General... (Filed With SEC on March 31, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on March 31, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 21, 2014)
- COMMON STOCK PURCHASE WARRANT BIOZONE PARMACEUTICALS, INC. (Filed With SEC on January 21, 2014)
- AGREEMENT AND PLAN OF MERGER BY AND AMONG BIOZONE PHARMACEUTICALS, INC., BIOZONE ACQUISITIONS CO., INC. AND COCRYSTAL DISCOVERY, INC. Dated as of January 2, 2014 Table of Contents (Filed With SEC on January 8, 2014)
- CERTIFICATE OF MERGER OF BIOZONE ACQUISITIONS CO., INC. (a Delaware corporation) WITH AND INTO COCRYSTAL DISCOVERY, INC. (a Delaware corporation)... (Filed With SEC on January 8, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 8, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 8, 2014)
- ASSET PURCHASE AGREEMENT by and among MUSCLEPHARM CORPORATION, BIOZONE LABORATORIES INC., and BIOZONE PHARMACEUTICALS, INC., BIOZONE LABORATORIES, INC., BAKER CUMMINS CORP. and... (Filed With SEC on November 13, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 31, 2013)
- COMMON STOCK PURCHASE WARRANT BIOZONE PARMACEUTICALS, INC. (Filed With SEC on October 31, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 30, 2013)
- BIOZONE PHARMACEUTICALS, INC. SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 30, 2013)
- BIOZONE PHARMACEUTICALS, INC. Warrant (Filed With SEC on August 30, 2013)
- SUBSCRIPTION AGREEMENT (Filed With SEC on April 18, 2013)
- WARRANT (Filed With SEC on April 18, 2013)
- FACTORING AND SECURITY AGREEMENT (Filed With SEC on April 1, 2013)
- PURCHASE MONEY FINANCING RIDER (Filed With SEC on April 1, 2013)
- GUARANTY AND SECURITY AGREEMENT THIS DOCUMENT CONTAINS A WAIVER OF TRIAL BY JURY (Filed With SEC on April 1, 2013)
- March____, 2013 (Filed With SEC on April 1, 2013)
- INTERCREDITOR AGREEMENT (Filed With SEC on April 1, 2013)
- SUPPLY AGREEMENT (Filed With SEC on January 31, 2013)
- SUPPLYAGREEMENT (Filed With SEC on January 14, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 28, 2012)
- BIOZONE PHARMACEUTICALS, INC. 10% PROMISSORY NOTE (Filed With SEC on July 5, 2012)
- BIOZONE PHARMACEUTICALS, INC. Warrant (Filed With SEC on July 5, 2012)
- STOCK PURCHASE AGREEMENT (Filed With SEC on July 2, 2012)
- SUPPLY AGREEMENT (Filed With SEC on July 2, 2012)
- BIOZONE PHARMACEUTICALS, INC. 10% PROMISSORY NOTE (Filed With SEC on June 20, 2012)
- BIOZONE PHARMACEUTICALS, INC. 10% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 24, 2012)
- BIOZONE PHARMACEUTICALS, INC. 10% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on March 16, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 1, 2012)
- BIOZONE PHARMACEUTICALS, INC. SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on March 1, 2012)
- BIOZONE PHARMACEUTICALS, INC. Warrant (Filed With SEC on March 1, 2012)
- PLEDGE AND SECURITY AGREEMENT (Filed With SEC on March 1, 2012)
- SUBSCRIPTION AGREEMENT (Filed With SEC on January 13, 2012)
- WARRANT (Filed With SEC on January 13, 2012)
- SUBSCRIPTION AGREEMENT (Filed With SEC on December 7, 2011)
- SUBSCRIPTION AGREEMENT (Filed With SEC on November 4, 2011)
- NOTE EXTENSION AGREEMENT (Filed With SEC on November 3, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 27, 2011)
- BIOZONE PHARMACEUTICALS, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 27, 2011)
- BIOZONE PHARMACEUTICALS, INC. Warrant (Filed With SEC on September 27, 2011)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 27, 2011)
- Form of LLC Membership Interest Purchase Agreement (Equalan LLC) (Filed With SEC on July 7, 2011)
- Form of Stock Purchase Agreement (BioZone Laboratories, Inc.) (Filed With SEC on July 7, 2011)
- Form of LLC Membership Interest Purchase Agreement (Equachem LLC) (Filed With SEC on July 7, 2011)
- Form of LLC Membership Interest Purchase Agreement (Betazone LLC) (Filed With SEC on July 7, 2011)
- Form of Lockup Agreement (Filed With SEC on July 7, 2011)
- Stock Option Agreement between Brian Keller and Opko Health, Inc (Filed With SEC on July 7, 2011)
- Stock Option Agreement between Daniel Fisher and Opko Health, Inc (Filed With SEC on July 7, 2011)
- Employment Agreement between the Company and Brian Keller (Filed With SEC on July 7, 2011)
- Employment Agreement between the Company and Daniel Fisher (Filed With SEC on July 7, 2011)
- Employment Agreement between the Company and Christian Oertle (Filed With SEC on July 7, 2011)
- License Agreement (Filed With SEC on July 7, 2011)
- Amendment No, 1 to License Agreement (Filed With SEC on July 7, 2011)
- Amendment No. 2 to License Agreeement (Filed With SEC on July 7, 2011)
- Asset Purchase Agreement (Filed With SEC on May 19, 2011)
- Assignment and Assumption Agreement (Filed With SEC on May 19, 2011)
- Bill of Sale (Filed With SEC on May 19, 2011)
- Amendment No.1 to Asset Purchase Agreement dated as of April 25, 2011 by and between Aero Pharmaceuticals, Inc. and Teva Respiratory, LLC (Filed With SEC on May 19, 2011)
- INTERNATIONAL SURF RESORTS, INC. Warrant (Filed With SEC on March 1, 2011)
- NON-RECOURSE PRINCIPAL STOCKHOLDER STOCK PLEDGE AGREEMENT (Filed With SEC on March 1, 2011)
- NTERNATIONAL SURF RESORTS, INC. DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on March 1, 2011)